Compass Oncology
- Research works
- 75 ◆ 0% vs 2013–17
- Citations
- 1.3k 17.2 per fractional work
- Top-10% rate
- 13.9% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: Compass Oncology is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.9×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 5.9×
- Veterinary 5.1×
- Economics, Econometrics and Finance 3.8×
- Medicine 3.7×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Dentistry 0.6×
- Health Professions 0.4×
- Arts and Humanities 0.2×
- Physics and Astronomy 0.2×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Social Sciences 0.0×
Who are the top researchers at Compass Oncology?
Ranked on the composite score, Manuel Modiano and Jay C. Andersen lead among researchers whose main affiliation is Compass Oncology.
- 1 Manuel Modiano United States · #836,510 worldwide 39 citations · 26 works
- 2 Jay C. Andersen United States · #1,289,252 worldwide 7 citations · 19 works
Which keywords describe research at Compass Oncology?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Survival Analysis, Rituximab, Palliative Care, Precision Medicine and Quality of Life.
- Genetic Pathogenesis
- Molecular Profiling
- Genetic Testing
- Mutational Signatures
- Cancer Genomics
- Metastasis
- Genomic Aberrations
- Lymphoma
- Brachytherapy
- PET Imaging
- Cancer Risk
- Molecular Classification
- Cervical Cancer
- Targeted Therapy
- Clinical Trials
- End-of-Life
- Precision Medicine
- Rituximab
- Survival Analysis
- Clinical Practice Guidelines
- Chemotherapy
- Prognostic Factors
- Quality of Life
- Palliative Care
- Breast Cancer
- Immunotherapy
- Radiation Therapy
- Sentinel Lymph Node Biopsy
- Radiotherapy
- Advance Care Planning
- Family Perspectives
- Robotic Surgery
- Endometrial Carcinoma
- Chronic Lymphocytic Leukemia
- Genomic Instability
- Molecular Subtypes
- Metastatic Breast Cancer
- Neoadjuvant Therapy
- Gene Expression Profiling
- Ovarian Cancer
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy7▲ 13×19 topics
- Clinical Practice Guidelines6▲ 14×8 topics
- Prognostic Factors6▲ 17×12 topics
- Survival Analysis5▲ 27×6 topics
- Quality of Life5▲ 4.9×13 topics
- Rituximab5▲ 40×3 topics
- Palliative Care4▲ 34×3 topics
- Precision Medicine4▲ 17×5 topics
- Breast Cancer4▲ 18×7 topics
- End-of-Life4▲ 60×2 topics
- Immunotherapy4▲ 7.0×10 topics
- Clinical Trials3▲ 7.3×11 topics
- Radiation Therapy3▲ 31×4 topics
- Targeted Therapy3▲ 21×4 topics
- Sentinel Lymph Node Biopsy3▲ 63×2 topics
- Cervical Cancer3▲ 40×2 topics
- Radiotherapy3▲ 10×10 topics
- Molecular Classification3▲ 25×2 topics
- Advance Care Planning3▲ 64×1 topic
- Cancer Risk3▲ 14×4 topics
- Family Perspectives3▲ 64×1 topic
- PET Imaging3▲ 16×4 topics
- Robotic Surgery3▲ 26×2 topics
- Brachytherapy2▲ 90×1 topic
- Endometrial Carcinoma2▲ 90×1 topic
- Lymphoma2▲ 23×2 topics
- Chronic Lymphocytic Leukemia2▲ 66×1 topic
- Genomic Aberrations2▲ 66×1 topic
- Genomic Instability2▲ 26×3 topics
- Metastasis2▲ 9.5×7 topics
- Molecular Subtypes2▲ 37×2 topics
- Cancer Genomics2▲ 56×1 topic
- Metastatic Breast Cancer2▲ 46×2 topics
- Mutational Signatures2▲ 56×1 topic
- Neoadjuvant Therapy2▲ 14×4 topics
- Genetic Testing2▲ 18×2 topics
- Gene Expression Profiling2▲ 29×2 topics
- Molecular Profiling2▲ 24×2 topics
- Ovarian Cancer2▲ 30×3 topics
- Genetic Pathogenesis2▲ 44×1 topic
Which research topics does Compass Oncology publish most on?
By volume in 2022–2025: Chronic Myeloid Leukemia Treatments, Colorectal Cancer Treatments and Studies, Chronic Lymphocytic Leukemia Research and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 2 Colorectal Cancer Treatments and Studies Oncology 1 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 5 Cancer Genomics and Diagnostics Cancer Research 1 works
- 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 8 BRCA gene mutations in cancer Genetics 0 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 10 Pharmacy and Medical Practices Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Compass Oncology's research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Portland
- Oregon Health & Science University
- Portland State University
- University of Portland
- Lewis & Clark College
- Reed College
- Portland VA Medical Center
- Pacific Northwest Research Station
- Oregon Medical Research Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.